African Green Monkey model of SARS-CoV-2 infection shows mild lung pathology and viral replication in the airways.

Dr Joachim Confais, Cynbiose & Cynbiose Respiratory’s CSO, will intervene at the I4ID congress during the pitch session dedicated to “New approaches to fighting SARS-CoV-2″ on December 9th, 2020.

His talk  will deal with our latest infectious model for COVID-19: “African Green Monkey model of SARS-CoV-2 infection shows mild lung pathology and viral replication in the airways”. He will unveil the results of the non-human primate efficacy model developed in collaboration with the VirPath academic laboratory.

This NHP model was implemented thanks to the COVIBIOSE project. This initiative is coordinated by the French cluster Lyonbiopôle and supported by the Auvergne-Rhône-Alpes region.

The 4^th edition of the Immunotherapies & Innovations for Infectious Diseases congress (I4ID) will largely address the current COVID-19 pandemics as well as other infectious diseases.